Skip to content

A comparison between two analgesia method in patients with upper extremity injury

A comparison of analgesia, duration of surgery, clinician and patients satisfaction and complications of Bier block versus conscious sedation methods in patients with upper extremity trauma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202289162N1
Enrollment
68
Registered
2013-01-31
Start date
2012-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Superficial injury of forearm. Condition 2: Open wound of forearm. Condition 3: Fracture of forearm. Condition 4: Dislocation, sprain and strain of joints and ligaments of elbow. Condition 5: Injury of blood vessels at forearm level. Condition 6: Injury of muscle and tendon at forearm level. Condition 7: Crushing injury of forearm. Condition 8: Other and unspecified injuries of forearm. Condition 9: Superficial injury of wrist and hand. Condition 10: Open wound of wrist and hand. Co

Interventions

Intervention 1: systemic analgesia: midazolam with a dose of 0.04mg/kg and phentanyl with a dose of 2 micrograms/kg. Intervention 2: Bier block: 30-50 of lidocaine solution with a dose of 0.5% is inje
Treatment - Surgery
Treatment - Drugs
systemic analgesia: midazolam with a dose of 0.04mg/kg and phentanyl with a dose of 2 micrograms/kg
Bier block: 30-50 of lidocaine solution with a dose of 0.5% is injected into local venous circulation during 7 minutes

Sponsors

AJA University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients with upper exterimity trauma; in need of analgesia; time of admission during years 2012 and 2013; place of admission Imam Khomeini and Beesat hospital, Tehran, Iran exclusion criteria:history of seizure; known allergy to analgesic substances; peripheral vascular disease; sickle cell anemia; AV fistula in upper exterimity; upper exterimity infection; procedures that lasts more than one hour; patients who need emergent intervention

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of analgesia. Timepoint: after performance of sedation method. Method of measurement: NSR (numerical scaling rate).

Secondary

MeasureTime frame
Satisfaction. Timepoint: after performance of sedation method. Method of measurement: five benchmark value.;Complications. Timepoint: after procedural sedation. Method of measurement: qualitative value.;Hemodynamic changes (pulse rate, mean arterial pressure). Timepoint: before and after procedural sedation, before initiation of prosedure, at the end of procedure, at the time of discharge. Method of measurement: cardiac monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Nikoo

Iranian national foundation of ellites

mohammadalinikoo@gmail.com002144242502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026